{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:23:46Z","timestamp":1790288626817,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.beha.2005.01.013","type":"journal-article","created":{"date-parts":[[2005,7,17]],"date-time":"2005-07-17T12:33:11Z","timestamp":1121603591000},"page":"635-652","source":"Crossref","is-referenced-by-count":59,"title":["Renal, hematologic and infectious complications in multiple myeloma"],"prefix":"10.1016","volume":"18","author":[{"given":"Joan","family":"Blad\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rosi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.01.013_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005792-197505000-00003","article-title":"Acute renal failure in multiple myeloma","volume":"54","author":"DeFronzo","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beha.2005.01.013_bib2","first-page":"29","article-title":"Multiple myeloma: review of 869 cases","volume":"50","author":"Kyle","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.013_bib3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/archinte.142.12.2083","article-title":"Reversible renal insufficiency in multiple myeloma","volume":"142","author":"Bersntein","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(84)90781-2","article-title":"Acute renal failure in patients with multiple myeloma","volume":"76","author":"Cohen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib5","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archinte.150.8.1693","article-title":"Renal failure in multiple myeloma: pathogenesis and prognostic implications","volume":"150","author":"Alexanian","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma. Presenting features and predictors of outcome in 94 patients from a single institution","volume":"158","author":"Blad\u00e9","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib7","series-title":"Multiple Myeloma and Related Disorders","first-page":"339","article-title":"Management of myeloma patients with renal failure","author":"Blad\u00e9","year":"2004"},{"key":"10.1016\/j.beha.2005.01.013_bib8","series-title":"Myeloma: Biology and Management","first-page":"251","article-title":"Management of renal, hematologic, and infectious complications","author":"Blad\u00e9","year":"2004"},{"key":"10.1016\/j.beha.2005.01.013_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0609.1994.tb00190.x","article-title":"Renal function in newly diagnosed multiple myeloma. A demographic study of 1353 patients","volume":"53","author":"Knudsen","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on prognosis","volume":"65","author":"Knudsen","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2141.1995.tb05400.x","article-title":"Patients with multiple myeloma and renal failure requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases","volume":"91","author":"Torra","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.150.4.863","article-title":"Treatment of renal failure associated to multiple myeloma","volume":"150","author":"Johnson","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01892092","article-title":"Renal lesions in dysproteinemia","volume":"5","author":"Verroest","year":"1982","journal-title":"Semin Immunopthol"},{"key":"10.1016\/j.beha.2005.01.013_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0272-6386(83)80075-4","article-title":"Renal lesions in multiple myeloma: their relationship to associated protein abnormalities","volume":"4","author":"Hill","year":"1983","journal-title":"Am J Kid Dis"},{"key":"10.1016\/j.beha.2005.01.013_bib15","first-page":"484","article-title":"Pathogenesis and treatment of myeloma kidney","volume":"124","author":"Sanders","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.beha.2005.01.013_bib16","first-page":"S93","article-title":"Structural features related to the nephropathogenicity of Bence Jones protein","volume":"46","author":"Boege","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.beha.2005.01.013_bib17","first-page":"1","article-title":"Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: review of 50 cases","volume":"28","author":"Pozzi","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.beha.2005.01.013_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005792-198703000-00004","article-title":"Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients","volume":"66","author":"Rota","year":"1987","journal-title":"Medicine"},{"key":"10.1016\/j.beha.2005.01.013_bib19","first-page":"247","article-title":"Long-term survival in patients with acute and severe renal failure due to multiple myeloma","volume":"34","author":"Pasqualli","year":"1990","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.beha.2005.01.013_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/cs0660229","article-title":"The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma","volume":"66","author":"Coward","year":"1984","journal-title":"Clin Sci"},{"key":"10.1016\/j.beha.2005.01.013_bib21","first-page":"138","article-title":"Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains","volume":"22","author":"Melcion","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.beha.2005.01.013_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM198203113061002","article-title":"\u2018Idiopathic\u2019 Bence Jones proteinuria: long-term follow-up in seven patients","volume":"306","author":"Kyle","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib23","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/10428190310001638841","article-title":"Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide","volume":"45","author":"Montagut","year":"2004","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.beha.2005.01.013_bib24","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.1994.12.11.2398","article-title":"Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases","volume":"12","author":"Blad\u00e9","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.013_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9343(76)90440-X","article-title":"Manifestations of systemic light chain deposition","volume":"60","author":"Randall","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1994.355","article-title":"Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains","volume":"46","author":"Preudhomme","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.beha.2005.01.013_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0889-8588(05)70417-2","article-title":"Biology and therapy of immunoglobulin deposition diseases","volume":"11","author":"Dhodapkar","year":"1997","journal-title":"Hemat Oncol Clin North Am"},{"key":"10.1016\/j.beha.2005.01.013_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2003-10-3400","article-title":"Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma","volume":"104","author":"Ma","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bmj.288.6428.1411","article-title":"Analysis and management of renal failure in the fourth myelomatosis trial","volume":"288","author":"Medical Research Council Working Party on Leukemia in Adults","year":"1984","journal-title":"Br Med J"},{"key":"10.1016\/j.beha.2005.01.013_bib30","first-page":"147","article-title":"Renal failure in multiple myeloma: a study of the presenting findings, response to treatment and prognosis in 26 patients","volume":"28","author":"Cavo","year":"1986","journal-title":"Nou Rev Fr Hematol"},{"key":"10.1016\/j.beha.2005.01.013_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0272-6386(87)80007-0","article-title":"Management of myeloma kidney: an anti-light chain approach","volume":"10","author":"Misiani","year":"1987","journal-title":"Am J Kid Dis"},{"key":"10.1016\/j.beha.2005.01.013_bib32","first-page":"903","article-title":"Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment","volume":"270","author":"Iggo","year":"1989","journal-title":"Q J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0272-6386(12)81021-3","article-title":"The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma","volume":"6","author":"Korzets","year":"1990","journal-title":"Am J Kid Dis"},{"key":"10.1016\/j.beha.2005.01.013_bib34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","article-title":"Effective treatment of advanced myelom refractory to alkylating agents","volume":"310","author":"Barlogie","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjc.1990.171","article-title":"Vincristine, adriamycin and high-dose steroids in myeloma complicated by renal failure","volume":"61","author":"Aitchison","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2005.01.013_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.thj.6200003","article-title":"Are myeloma patients with renal failure candidates for autologous stem cell transplantation?","volume":"1","author":"San Miguel","year":"2000","journal-title":"Hematol J"},{"key":"10.1016\/j.beha.2005.01.013_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2141.2001.03033.x","article-title":"Results of autologous stem cell transplant in multiple myeloma with renal failure","volume":"114","author":"Badros","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1704440","article-title":"Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant","volume":"33","author":"Lee","year":"2004","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.beha.2005.01.013_bib39","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V99.12.4276","article-title":"Autologous stem cell transplantation for primary systemic amyloidosis","volume":"99","author":"Comenzo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib40","first-page":"65","article-title":"Dialysis in the treatment of multiple myeloma","volume":"55","author":"Johnson","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.013_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.013_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.thj.6200115","article-title":"Initial treatment of multiple myeloma: long-term results in 914 patients","volume":"2","author":"Blad\u00e9","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.beha.2005.01.013_bib43","series-title":"Myeloma: Biology and Management","first-page":"332","article-title":"Management of hematologic complications of myeloma","author":"Meharchand","year":"1998"},{"key":"10.1016\/j.beha.2005.01.013_bib44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease","volume":"80","author":"Means","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2141.1992.tb06939.x","article-title":"Erythropoiesis in multiple myeloma: defective red cell production","volume":"82","author":"Berguin","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0609.1990.tb00374.x","article-title":"Correlation between neopterin, interferon gamma and haemoglobin in patients with haematologic disorders","volume":"44","author":"Denz","year":"1990","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib47","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","article-title":"Effect of inflammatory cytokines on hypoxia-induced erythripoietin production","volume":"79","author":"Faquin","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib48","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/1042819021000002848","article-title":"Anemia in multiple myeloma: role of deregulated plasma cell apoptosis","volume":"43","author":"Tucci","year":"2002","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.beha.2005.01.013_bib49","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","article-title":"Erythropoietin treatment of anemia associated with multiple myeloma","volume":"322","author":"Ludwig","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib50","first-page":"574a","article-title":"Identifying hemoglobin level for optimal quality of life: results from an incremental analysis","volume":"8","author":"Cleeland","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.013_bib51","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2002-06-1767","article-title":"Use of epoietin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology","volume":"100","author":"Rizzo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2002.07.177","article-title":"Use of epoietin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and The American Society of Hematology","volume":"20","author":"Rizzo","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.013_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.thj.6200160","article-title":"Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations","volume":"3","author":"Ludwig","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.beha.2005.01.013_bib54","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib55","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM197910043011402","article-title":"The chemotherapy of plasma cell myeloma and the incidence of acute leukemia","volume":"301","author":"Bergsagel","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hon.2900060216","article-title":"Chemotherapy of myeloma: drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma","volume":"6","author":"Bergsagel","year":"1988","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.beha.2005.01.013_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0609.2000.90218.x","article-title":"Acute leukemia ad other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukemia Group Study","volume":"65","author":"Finnish Leukemia Group","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/bjc.1987.107","article-title":"A comparison of the incidence of myelodysplastic syndrome and acute myeloid leukemia following melphalan and cyclophosphamide treatment of myelomatosis","volume":"55","author":"Cuzick","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2005.01.013_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10428199909167402","article-title":"Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature","volume":"32","author":"Anderson","year":"1999","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.beha.2005.01.013_bib60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0308-2261(21)00329-5","article-title":"Plasma cell neoplasms and acute leukemia","volume":"11","author":"Bergsagel","year":"1982","journal-title":"Clin Hematol"},{"key":"10.1016\/j.beha.2005.01.013_bib61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(84)91005-2","article-title":"Simultaneous occurrence of multiple myeloma and acute myeloblastic leukemia: fact or myth?","volume":"76","author":"Rosner","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2141.1996.d01-1891.x","article-title":"Preceding standard therapy is the likely cause of MDS after autologous transplantation for multiple myeloma","volume":"95","author":"Govindarajan","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib63","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.V97.6.1885","article-title":"Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations and response to high-dose therapy","volume":"97","author":"Choufani","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib64","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1200\/JCO.2003.07.200","article-title":"Treatment of plasma cell dyscrasias with thalidomide and its derivates","volume":"21","author":"Dimopoulos","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.013_bib65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.2004.05078.x","article-title":"Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation","volume":"126","author":"Zangari","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib66","series-title":"Myeloma","first-page":"223","article-title":"Infections: principles of prevention and therapy","author":"Kelleher","year":"2002"},{"key":"10.1016\/j.beha.2005.01.013_bib67","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archinte.1959.00270020001001","article-title":"A review of 51 cases of multiple myeloma: emphasis on pneumonia and other infections as complications","volume":"103","author":"Clenchur","year":"1959","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib68","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.7326\/0003-4819-41-6-1152","article-title":"Recurrent pneumonia in multiple myeloma and some observations on immunological response","volume":"41","author":"Zinneman","year":"1954","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib69","first-page":"280","article-title":"Immunosupression and infection in multiple myeloma","volume":"13","author":"Jacobson","year":"1986","journal-title":"Semin Oncol"},{"key":"10.1016\/j.beha.2005.01.013_bib70","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJM197510302931801","article-title":"Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma","volume":"193","author":"Border","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib71","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9343(63)90140-2","article-title":"Infection, antibody response and gammaglobulin components in multiple myeloma and macroglobulinemia","volume":"35","author":"Fahey","year":"1963","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jcp.48.3.260","article-title":"Immunological factors and risk of infection in plateau phase myeloma","volume":"48","author":"Hargreaves","year":"1995","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.beha.2005.01.013_bib73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.1983.tb02021.x","article-title":"Abnormal monoclonal antibody-defined helper\/suppressor T-cell subpopulations in multiple myeloma: relation to treatment and clinical stage","volume":"53","author":"Mills","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib74","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood.V55.4.602.602","article-title":"Defective opsonization in multiple myeloma","volume":"55","author":"Cheson","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajh.2830230302","article-title":"Serum bactericidal and opsonic activities in chronic lymphocytic leukemia and multiple myeloma","volume":"23","author":"Kansu","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2005.01.013_bib76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-0609.1984.tb00682.x","article-title":"Mechanisms of decreased leukocyte adhesiveness and migration in plasma from patients with IgG myelomatosis","volume":"32","author":"Hopen","year":"1984","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.V51.4.591.591","article-title":"Impaired granulocyte adherence in multiple myeloma: relationship to complement system, granulocyte delivery, and infection","volume":"51","author":"MacGregor","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.013_bib78","first-page":"1022","article-title":"Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine\u2013adriamycin\u2013dexamethasone schedules","volume":"88","author":"Cesana","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2005.01.013_bib79","first-page":"377","article-title":"Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicentre prospective survey","volume":"10","author":"Hoen","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.beha.2005.01.013_bib80","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(94)93028-7","article-title":"Frequency of infection in plateau-phase multiple myeloma (Letter)","volume":"344","author":"Snowdon","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2005.01.013_bib81","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9343(72)90010-1","article-title":"Current pattern of infection in multiple myeloma","volume":"52","author":"Meyers","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib82","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000225611","article-title":"Changing patterns of infections in patients with multiple myeloma","volume":"39","author":"Shaikh","year":"1982","journal-title":"Oncology"},{"key":"10.1016\/j.beha.2005.01.013_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2005.01.013_bib84","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9343(81)90303-X","article-title":"Influence of treatment and response status on infection in multiple myeloma","volume":"71","author":"Perri","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib85","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0889-8588(05)70122-2","article-title":"Amyloidosis","volume":"13","author":"Gertz","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.beha.2005.01.013_bib86","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0002-9343(95)00043-7","article-title":"Prophylactic antibiotics for the prevention of early infection in multiple myeloma","volume":"100","author":"Oken","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib87","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-0609.1983.tb01500.x","article-title":"Antibody response to pneumococcal vaccination in patients with myelomatosis","volume":"30","author":"Birgens","year":"1983","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.beha.2005.01.013_bib88","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9343(80)90014-5","article-title":"Pneumococcan vaccination: the response of patients with multiple myeloma","volume":"69","author":"Lazarus","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.013_bib89","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/143.4.590","article-title":"Antibody response to pneumococcal vaccine in patients with multiple myeloma","volume":"143","author":"Schmith","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.beha.2005.01.013_bib90","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/1097-0142(19810915)48:6<1377::AID-CNCR2820480620>3.0.CO;2-T","article-title":"Polyvalent pneumococcal immunization of patients with plasma cell dyscrasias","volume":"48","author":"Shildt","year":"1981","journal-title":"Cancer"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T17:43:49Z","timestamp":1626198229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1521692605000149"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.01.013","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}